Moehs Group, a reference company in the production of pharmaceutical active ingredients.
01 1Moehs Catalana SL
02 1Supriya Lifescience Limited
03 1AX Pharmaceutical Corp
04 1Apex Healthcare Limited
05 1B&B Pharmaceuticals, Inc.
06 1Cambrex Karlskoga AB
07 1DARMERICA, LLC
08 1Delta Synthetic Co. Ltd
09 1Fagron Inc
10 1Galenova Inc
11 1Harman Finochem Limited
12 1KALCHEM INTERNATIONAL INC
13 1LETCO MEDICAL, LLC
14 1Medisca Inc.
15 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
16 1Professional Compounding Centers of America
17 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
18 1Spectrum Laboratory Products, Inc.
19 3Swati Spentose Private Limited
20 1W. R. GRACE & CO.-CONN.
21 1Xenex Laboratories Inc
22 1Zen Chemicals Private Limited
01 6LIDOCAINE
02 1LIDOCAINE BASE
03 17Lidocaine
01 3Canada
02 6India
03 1Italy
04 1Japan
05 1Netherlands
06 1Spain
07 1Taiwan
08 8U.S.A
09 2United Kingdom
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
NDC Package Code : 52932-0702
Start Marketing Date : 2009-09-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
NDC Package Code : 61281-2500
Start Marketing Date : 2011-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12651-124
Start Marketing Date : 2023-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0145
Start Marketing Date : 1998-04-01
End Marketing Date : 2027-03-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 22568-1014
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0081
Start Marketing Date : 2012-04-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0269
Start Marketing Date : 2013-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0345
Start Marketing Date : 2024-07-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12660-0033
Start Marketing Date : 1989-02-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4040
Start Marketing Date : 2000-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A LIDODERM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LIDODERM, including repackagers and relabelers. The FDA regulates LIDODERM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LIDODERM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LIDODERM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LIDODERM supplier is an individual or a company that provides LIDODERM active pharmaceutical ingredient (API) or LIDODERM finished formulations upon request. The LIDODERM suppliers may include LIDODERM API manufacturers, exporters, distributors and traders.
click here to find a list of LIDODERM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LIDODERM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LIDODERM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LIDODERM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LIDODERM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LIDODERM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LIDODERM suppliers with NDC on PharmaCompass.
We have 21 companies offering LIDODERM
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
